Comment from Center on Reproductive Health, Law, and Policy
AnonymousSupportAcademic
Summary: A group of adolescent health researchers and clinicians argue that mifepristone is safe and effective for use by minors, citing clinical data and pharmacological evidence. They urge the FDA to ensure continued access to the medication without age-based restrictions, specifically refuting claims that it poses risks to the developing bodies of adolescents.
We submit this comment to provide context on the safety and efficacy of mifepristone in minor adolescents.